Advertising Disclosure

Could TrumpRX save money for seniors on Medicare? It depends

In most cases, Medicare recipients are better off using Part D

Updated:

Avatar photo
By:
Avatar photo

Mark Huffman
Reporter

Mark Huffman has covered consumer issues since 2004, with a special focus on protecting and empowering older adults. A former news correspondent for the Associated Press Radio Network, Westwood One, and ConsumerAffairs, Mark brings decades of journalistic experience to RetirementLiving.com. He is passionate about giving consumers a voice and helping them make informed decisions. Mark has also created educational content, including Senior Scam Alert, a video resource designed to help seniors recognize and avoid fraud. He holds a B.A. from the University of Kentucky and lives with his family in Richmond, Virginia.
national-cancer-institute-unsplash

Photo by National Cancer Institute on Unsplash

Key Insights

  • Most Medicare seniors are unlikely to save using TrumpRX if their prescriptions are already covered by Medicare Part D or Medicare Advantage drug plans.
  • Some could see savings in limited cases, such as when a drug isn’t covered or has a high out-of-pocket cost under their plan.
  • Paying through TrumpRX usually means paying cash, which can undercut Medicare’s protections against high drug costs.

A new prescription drug initiative known as TrumpRX is drawing attention with promises of lower drug prices. But for seniors enrolled in Medicare, the potential savings are far from guaranteed — and in many cases, the program may offer little financial benefit at all.

TrumpRX is being described as a drug-pricing and purchasing platform designed to highlight lower-priced medications and, in some cases, allow consumers to buy drugs outside traditional insurance channels. That distinction is crucial for Medicare beneficiaries, who already receive prescription coverage through Medicare Part D or Medicare Advantage plans.

Why Medicare coverage usually wins

Medicare drug plans negotiate prices with pharmaceutical companies and pharmacies, often resulting in relatively low copayments for common medications. For many seniors, a $5 to $20 copay under Part D is hard to beat.

Because TrumpRX generally operates outside the Medicare system, purchases made through the program typically do not count toward Medicare deductibles or annual out-of-pocket limits. That means a senior might pay less upfront for a single prescription but lose the long-term financial protections built into Medicare drug coverage.

That said, there are scenarios where TrumpRX could provide savings for Medicare beneficiaries:

  • Drugs not covered by a Medicare plan, such as certain newer or brand-name medications
  • Medications placed on a high-cost tier, where coinsurance can be significant
  • Short-term needs, when a senior is waiting for coverage to begin or resolve a coverage dispute

In those cases, comparing a TrumpRX cash price with the Medicare plan’s price could make sense — especially for one-time or occasional prescriptions.

Risks seniors should consider

Experts caution that seniors should be careful before bypassing their Medicare drug coverage. Paying cash through TrumpRX may reduce progress toward catastrophic coverage thresholds and could result in higher overall spending during the year.

There’s also the issue of price variability. A drug that appears cheaper through TrumpRX today may not remain cheaper than a Medicare-negotiated price, especially once pharmacy discounts and plan subsidies are factored in.

For most seniors on Medicare, TrumpRX is unlikely to replace or outperform Medicare drug coverage. Its value, if any, lies in serving as a comparison tool or a fallback option when Medicare coverage falls short.

The safest approach for seniors: check the Medicare plan price first, then compare it with any TrumpRX offer — and remember that the lowest sticker price isn’t always the lowest cost in the long run.